Damages in life sciences arbitrations
In “Damages in life sciences arbitrations”, a chapter published in The Guide to Damages in International Arbitration, we explore arbitrated disputes in the...
Dr. Justin Ho is a Principal in the Life Sciences Practice. He specializes in industrial organization and the economic and strategic evaluation of firm behavior and contracting.
Dr. Ho’s research includes the welfare and competitive effects of new product and contract introduction. He has worked on matters involving a range of products, including biologics, small-molecule drugs, and medical devices. His experience includes disputes on efforts in drug development (including the license disputes and interpretation), antitrust matters (market definition and damages in reverse-payment settlements, and product tying), intellectual property disputes (evaluation of commercial success, reasonable royalty, and lost profit analyses), pricing (price fixing and welfare analyses), and product labeling matters (including both consumer and pharmaceutical product claims).